Collegium Pharmaceutical, Inc. COLL Goodwill
Goodwill at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Goodwill.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s goodwill.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s goodwill?
- Collegium Pharmaceutical, Inc. (COLL) reported goodwill of $145.93M in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s goodwill changed year-over-year?
- Collegium Pharmaceutical, Inc.'s goodwill decreased by 3.2% year-over-year, from $150.76M to $145.93M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s goodwill?
- Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s goodwill has grown at a -15.4% compound annual growth rate (CAGR), from $335.9M to $145.93M.
- What does goodwill mean?
- The excess of acquisition cost over the fair value of net identifiable assets acquired — representing brand value, customer relationships, and synergies from past M&A.